Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Angiogenic Pathway Activation Multiple components contribute to blood vessel formation through distinct but complementary mechanisms: BPC-157 upregulates VEGFR2 expression and enhances endothelial cell proliferation TB-500 promotes endothelial cell migration and tube formation GHK-Cu stimulates angiogenic growth factor expression and vessel maturation Combined effects result in improved tissue vascularization and nutrient delivery Anti-Inflammatory Pathway Modulation The blend provides comprehensive inflammation control through multiple targets: BPC-157 modulates nitric oxide synthesis and reduces pro-inflammatory cytokines TB-500 influences inflammatory mediator expression through cytoskeletal mechanisms GHK-Cu reduces oxidative stress and modulates immune cell function Coordinated effects help resolve inflammation while promoting healing Synergistic Advantage: GLOW Blends multi-pathway approach enables simultaneous activation of cellular migration, matrix synthesis, angiogenesis, and inflammation control
Choose based on your primary goal and comfort with injections
Mon - Fri: 9:00AM - 5:00PM 9301 Wilshire Blvd Suite 405, Beverly Hills, CA 90210 Although the FDA has yet to approve BPC-157 for humans, studies show that it has beneficial effects on stroke, schizophrenia, and spinal cord injury [1]
How Peptide Therapy Compares to Other Treatments Many patients ask how peptide therapy compares to other treatments
BPC-157 $33.40 $54.40 BPC-157 lyophilized research peptide, available in 5mg and 10mg variations
US$ 21.15
US$ 27.53
US$ 26.78
US$ 20.85
